Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event
- Conditions
- Oropharyngeal DysphagiaApparent Life Threatening EventBrief Resolved Unexplained Event
- Interventions
- Dietary Supplement: Thickened feedsDietary Supplement: Non-thickened feeds
- Registration Number
- NCT04477460
- Lead Sponsor
- Boston Children's Hospital
- Brief Summary
This observational study will examine the effects of thickened feeds on clinical outcomes and healthcare utilization in infants with brief resolved unexplained event (BRUE).
- Detailed Description
Brief resolved unexplained events (BRUE) are frightening episodes characterized by the appearance of life-threatening choking, pallor, cyanosis, and limpness in infants. These common events are resource-intensive and current management approaches inadequately address persistent symptoms. Infants with BRUE commonly have oropharyngeal dysphagia with aspiration, which is a modifiable risk factor for persistent symptoms, but there are no studies determining the mechanism behind this swallowing dysfunction and if swallowing interventions reduce morbidity. This is a prospective, longitudinal cohort study of infants who experienced brief resolved unexplained event receiving thickened feedings compared to those not receiving thickened feedings over 1 year.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250
- Less than 1 year of age
- Admitted to Boston Children's Hospital after experiencing first lifetime brief resolved unexplained event.
- Any pre-existing medical diagnoses that exclude brief resolved unexplained event diagnosis including seizure disorders and cyanotic congenital heart disease
- Already receiving thickened liquids for treatment of another condition
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Infants with BRUE receiving thickened feeds Thickened feeds - Infants with BRUE not receiving thickened feeds Non-thickened feeds -
- Primary Outcome Measures
Name Time Method Frequency of persistent symptoms and repeat hospitalizations over 6-month follow-up period 6 months Frequency of persistent symptoms and repeat hospitalizations over the 6 months after enrollment, with a comparison between those receiving and not receiving thickened feeds.
- Secondary Outcome Measures
Name Time Method Frequency of persistent symptoms and hospitalization risk over the full 12-month follow-up period 12 months Symptoms and hospitalization risk over the full 12-month follow-up period, optimal period of time needed for thickening, parent-reported anxiety levels, cost of care at Boston Children's Hospital, potential adverse effects of thickening, and urine arsenic levels, all compared between subjects receiving and not receiving thickened feeds.
Trial Locations
- Locations (1)
Boston Children's Hospital
🇺🇸Boston, Massachusetts, United States